Omeros Stock

Omeros EPS

The Earnings per Share (EPS) of Omeros (OMER) as of Aug 9, 2026 is -0.05 USD. In the previous year, Earnings per Share (EPS) was -2.70 USD — a change of -98.04% (higher).

EPS

-0.05USD

YoY

-98.04%

Last updated:

Earnings per Share (EPS) of Omeros is 2026 -0.05 USD. Earnings per Share (EPS) of Omeros was 2025 -2.70 USD. It decreases by -98.04% higher compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Earnings per Share (EPS) of Omeros is -0.05 USD in 2026.

Earnings per Share (EPS) of Omeros changed from -2.70 USD to -0.05 USD, representing a -98.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Omeros since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Omeros

All Key Metrics — Omeros